Joe GN Garcia

Company: Aqualung Therapeutics

Job title: AVP for Research, Professor of Medicne, Director Center for Inflammation Sciences


DAMPening Innate Immunity-Mediated Inflammatory Injury & Fibrosis via the eNAMPT-Neutralizing ALT-100 mAb 4:15 pm

• Explore the MOA behind ALT-100 mAb, a monoclonal antibody targeting eNAMPT, to dampen innate immunity-mediated inflammatory injury and fibrosis • Delve into the interplay between DAMP signaling and innate immunity, highlighting how the inhibition of eNAMPT holds promise in mitigating inflammatory responses implicated in pulmonary fibrosis progression.Read more

day: Day Two

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.